Coordination-guided design of triazole-based Cu(ii) and Pt(iv) complexes: synthesis, characterization, theoretical studies, molecular docking and anticancer activity.

Authors

Hassan Khudher Naji, Rehab A M Al Hassani, Asim A Balakit, Mohammed Obies, Basil A Saleh, Majid S Jabir

Published in

RSC advances. Oct 16, 2026. Epub Oct 16, 2026.

Abstract

A new triazole-based ligand (L) was synthesized via a Schiff base condensation between 4-6-methoxy-2-naphthaldehyde and amino-5-(3,4,5-trimethoxyphenyl)-2H-1,2,4-triazole-3-thione, and its structure was confirmed using FT-IR, NMR, and UV-vis spectroscopy and mass spectrometry analysis. The ligand L was complexed with Cu(ii) and Pt(iv) ions to yield LCu and LPt complexes, respectively. The synthesized complexes were characterized by FT-IR spectroscopy, elemental analysis, UV-vis spectroscopy and magnetic susceptibility measurements. The spectroscopic and magnetic measurements indicated square planar and octahedral geometries for the LCu and LPt complexes, respectively, consistent with the results from DFT and TD-DFT calculations. Theoretical investigations confirmed the experimental UV-vis transitions and revealed pronounced metal-ligand charge transfer features. Cytotoxic evaluation against the SK-OV-3 ovarian cancer and HDFa normal cell lines demonstrated a marked improvement in the anticancer activity upon coordination, with LPt showing the lowest IC₅₀ value (24.85 µg mL^-1) and the highest selectivity index (16.54). Molecular docking studies with tubulin (PDB: 8QEA) and estrogen receptor α (PDB: 3ERT) supported these findings, showing the strong binding affinity of LPt (-6.920 kcal mol^-1) mediated by hydrogen bonding with ASN256 (2.97 Å, 1.4 kcal mol^-1) and π-H interactions between its six-membered ring system and PRO259 (4.62 Å, -0.6 kcal mol^-1). Overall, the designed triazole ligand represents an effective molecular scaffold, and its Pt(iv) complex (LPt) emerges as a promising anticancer agent targeting microtubule polymerization and estrogen receptor pathways.

PMID:
42891395
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.